SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314 | -50.3% | 131,847 | 0.0% | 0.04% | -43.5% |
| Q2 2023 | $632 | -99.9% | 131,847 | 0.0% | 0.06% | -21.5% |
| Q1 2023 | $747,572 | +1.2% | 131,847 | 0.0% | 0.08% | -14.1% |
| Q4 2022 | $738,343 | -12.7% | 131,847 | 0.0% | 0.09% | -12.4% |
| Q3 2022 | $846,000 | +87.2% | 131,847 | 0.0% | 0.10% | +101.9% |
| Q2 2022 | $452,000 | -51.9% | 131,847 | 0.0% | 0.05% | -45.3% |
| Q1 2022 | $939,000 | -14.5% | 131,847 | 0.0% | 0.10% | -7.8% |
| Q4 2021 | $1,098,000 | +19.6% | 131,847 | 0.0% | 0.10% | +90.7% |
| Q3 2021 | $918,000 | -70.8% | 131,847 | 0.0% | 0.05% | -70.2% |
| Q2 2021 | $3,145,000 | +15.8% | 131,847 | 0.0% | 0.18% | +19.1% |
| Q1 2021 | $2,715,000 | -15.9% | 131,847 | 0.0% | 0.15% | -13.1% |
| Q4 2020 | $3,230,000 | – | 131,847 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $129,455,452 | 4.13% |
| Eversept Partners, LP | 2,200,999 | $12,325,594 | 1.08% |
| Kynam Capital Management, LP | 776,662 | $4,349,307 | 0.67% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 374,422 | $2,096,763 | 0.60% |
| Lion Point Capital, LP | 596,803 | $3,109,000 | 0.44% |
| Knott David M Jr | 200,100 | $1,121 | 0.42% |
| FEDERATED HERMES, INC. | 18,085,938 | $101,281,253 | 0.28% |
| Atom Investors LP | 95,520 | $534,912 | 0.27% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 20,200 | $113,120 | 0.09% |
| HARBOURVEST PARTNERS LLC | 49,363 | $276,433 | 0.09% |